Tag: FDA

FDA: Class I recall of certain Datascope/Getinge IABPs

Editor's Note The Food and Drug Administration (FDA) on March 17 identified the recall by Datascope/Getinge of certain Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because the coiled cable connecting the display and base on some units may fail,…

Read More

By: Judy Mathias
March 20, 2023
Share

Update to Class I recall of GE HealthCare’s Nuclear Medicine 600/800 Series systems

Editor's Note The Food and Drug Administration (FDA) on February 22 updated the Class I recall of GE HealthCare’s Nuclear Medicine 600/800 Series systems. The recall was initiated by GE HealthCare after identifying an issue with two mechanisms that prevent uncontrolled detector movement—a risk that the ball screw, which serves…

Read More

By: Judy Mathias
February 23, 2023
Share

FDA: Class I recall of certain Philips Respironics ventilators

Editor's Note The Food and Drug Administration (FDA) on February 16 identified the recall by Philips Respironics of certain reworked Trilogy 100, Trilogy 200, and Garbin Plus ventilators as Class I, the most serious. The recall was initiated because of the potential for silicone foam adhesive failure and residual polyester-based…

Read More

By: Judy Mathias
February 21, 2023
Share

FDA: Class I recall of GE HealthCare’s Nuclear Medicine 600/800 Series systems

Editor's Note The Food and Drug Administration (FDA) on February 15 identified the recall by GE HealthCare of its Nuclear Medicine 600/800 Series systems as Class I, the most serious.  The recall was initiated because of an issue with two mechanisms that prevent uncontrolled detector movement. If the mechanisms fail,…

Read More

By: Judy Mathias
February 16, 2023
Share

FDA: Class I recall of Skippack Medical Lab COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on February 8 identified the recall by Universal Meditech Inc of its Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance,…

Read More

By: Judy Mathias
February 14, 2023
Share

FDA: Class I recall of Smiths Medical CADD Infusion System Administration Sets, Cassette Reservoirs

Editor's Note The Food and Drug Administration (FDA) on February 2 identified the recall by Smiths Medical of certain CADDTM Infusion System Administration Sets and Cassette Reservoirs as Class I, the most serious. The recall was initiated because of tubing occlusion and false “no disposable attached” alarm issues, which may…

Read More

By: Judy Mathias
February 10, 2023
Share

FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters

Editor's Note The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious. The recall was initiated because of a potential catheter hub defect that may cause…

Read More

By: Judy Mathias
February 1, 2023
Share

FDA: Addition to Class I recall of LivaNova LifeSPARC System Controller

Editor's Note The Food and Drug Administration (FDA) on January 27 posted an addition to the Class I recall by LivaNova (TandemLife) of its LifeSPARC System Controller. The addition to the recall provides information about a software update now available to address the previous software malfunction and recall. The System…

Read More

By: Judy Mathias
January 30, 2023
Share

Study: Unsafe medical devices gain FDA approval through loophole

Editor's Note A study done by investigators from Yale, Harvard, and the University of California-San Francisco, published on January 10 in JAMA, found that “many medical devices subject to recall had received Food and Drug Administration (FDA) approval based, in part, on the products’ similarities to earlier devices,” Healthcare Purchasing…

Read More

By: Tarsilla Moura
January 27, 2023
Share

FDA issues warning letters to endoscope manufacturer

Editor's Note The Food and Drug Administration (FDA) on January 10 announced that it had recently issued two warning letters to Olympus Medical Systems Corporation and one of its subsidiaries, Aizu Olympus Co, Ltd, after facility inspections. The letters addressed violations related to medical device reporting (MDR) requirements and quality…

Read More

By: Judy Mathias
January 12, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat